Infectious Disease

Recipient outcomes similar to kidneys from noninfected donors

Findings regardless of antibiotic class and with a dose-response relationship

Elevated C-reactive protein during hospitalization associated with increased mortality risk after recovery from COVID-19

Estimated vaccine efficacy with two doses was 88.0 percent against COVID-19 at a time when delta was dominant circulating variant

Persistent viral shedding associated with in-hospital delirium and increased six-month mortality

Improvements seen in physical and mental health, but survivors still have more symptoms than controls at two years

President Biden has ordered U.S. flags to be flown at half-staff in honor of those lost

Reduction in viral load from baseline greater with lenacapavir versus placebo among those with multidrug-resistant HIV-1 infection

Significant but weaker associations with selected adverse outcomes seen for preexisting hypertension, diabetes, and ischemic heart disease

However, masking rules may still vary by airline if regulations are different in the locations they fly to or from